United Services Automobile Association’s Sinovac Biotech, Ltd SVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-346,215
Closed -$2.04M 1428
2016
Q4
$2.04M Hold
346,215
0.01% 980
2016
Q3
$2.04M Sell
346,215
-12,363
-3% -$72.7K 0.01% 975
2016
Q2
$2.13M Hold
358,578
0.01% 930
2016
Q1
$2.29M Buy
358,578
+52,190
+17% +$313K 0.01% 888
2015
Q4
$1.75M Hold
306,388
0.01% 965
2015
Q3
$1.56M Buy
+306,388
New +$1.62M 0.01% 981

Other funds holding SVA

United Services Automobile Association's SVA Position: Q1 2017 in Review

United Services Automobile Association sold out of Sinovac Biotech, Ltd (SVA) in Q1 2017, closing a stake of 346,215 shares — an estimated $2.04M sold.

United Services Automobile Association first reported a position in SVA in Q3 2015 and held it in 6 quarters. The position peaked at $2.29M in Q1 2016. 35 funds tracked by Wall St. Rank hold SVA as of Q1 2017.

  • United Services Automobile Association reported no remaining Sinovac Biotech, Ltd position as of Q1 2017 after selling out during the quarter.
  • United Services Automobile Association sold 346,215 Sinovac Biotech, Ltd shares in Q1 2017, an estimated $2.04M.
  • United Services Automobile Association first reported a position in Sinovac Biotech, Ltd in Q3 2015 and held it in 6 quarters.
  • United Services Automobile Association's Sinovac Biotech, Ltd position peaked at $2.29M in Q1 2016.
  • 35 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2017.

Based on United Services Automobile Association's 13F filing for Q1 2017, filed 11 May 2017.